News Image

Affimed Announces Filing for the Opening of Insolvency Proceedings

Provided By GlobeNewswire

Last update: May 13, 2025

MANNHEIM, Germany, May 13, 2025 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today announced its decision to file an application for opening of insolvency proceedings with the local court of Mannheim in Germany.

Read more at globenewswire.com
Follow ChartMill for more